Mediwound Ltd Ord Sh (MDWD)

$17.57 -0.58 (-3.20%)
Market Cap 232.59M
Revenue (ttm) 20.22M
Net Income (ttm) -30.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -149.46%
Debt to Equity Ratio 0.02
Volume 27,700
Avg Vol 102,160
Day's Range N/A - N/A
Shares Out 12.82M
Stochastic %K 49%
Beta 0.13
Analysts Strong Sell
Price Target $31.50

Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and ot...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 7 797 14100
Fax: 972 7 797 14111
Address:
42 Hayarkon Street, Yavne, Israel
novelty
novelty Feb. 25 at 2:19 AM
$MDWD has to be the easiest short in the market. Dont even need to trade many shares for this thing to drop 5% rofl
0 · Reply
novelty
novelty Feb. 24 at 8:35 PM
$MDWD who buys this garbage?
0 · Reply
novelty
novelty Feb. 24 at 8:27 PM
$MDWD every share sold yesterday rofl
0 · Reply
novelty
novelty Feb. 24 at 8:26 PM
$MDWD every single penny wiped out today. Gotta love this pig. 1000000000$ short from 18
0 · Reply
novelty
novelty Feb. 24 at 7:55 PM
$MDWD puke lil piggy
0 · Reply
novelty
novelty Feb. 24 at 7:25 PM
$MDWD hahahaha
0 · Reply
novelty
novelty Feb. 24 at 7:23 PM
$MDWD don’t u guys ever learn? It always give back every single penny
0 · Reply
novelty
novelty Feb. 24 at 6:36 PM
$MDWD the stock that can’t catch a bid. Rofl
0 · Reply
novelty
novelty Feb. 24 at 6:34 PM
$MDWD nothing but big sellers yesterday exiting their longs cause they know they’re getting em back at 14$ or less
0 · Reply
novelty
novelty Feb. 24 at 6:27 PM
$MDWD Ha A Ha
0 · Reply
Latest News on MDWD
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results

Feb 19, 2026, 8:00 AM EST - 6 days ago

MediWound to Report Fourth Quarter and Full Year 2025 Financial Results

MediWound to Present at Upcoming Investor Conferences

Feb 17, 2026, 8:00 AM EST - 8 days ago

MediWound to Present at Upcoming Investor Conferences

MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference

Jan 12, 2026, 7:00 AM EST - 6 weeks ago

MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference

MediWound Reports New Clinical Data Demonstrating NexoBrid®'s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries

Dec 10, 2025, 7:00 AM EST - 2 months ago

MediWound Reports New Clinical Data Demonstrating NexoBrid®'s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries

MediWound Ltd. (MDWD) Q3 2025 Earnings Call Transcript

Nov 20, 2025, 10:43 AM EST - 3 months ago

MediWound Ltd. (MDWD) Q3 2025 Earnings Call Transcript

MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 20, 2025, 7:00 AM EST - 3 months ago

MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update

MediWound to Report Third Quarter 2025 Financial Results

Nov 5, 2025, 7:30 AM EST - 4 months ago

MediWound to Report Third Quarter 2025 Financial Results

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

Nov 3, 2025, 8:00 AM EST - 4 months ago

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares

Sep 29, 2025, 8:37 AM EDT - 5 months ago

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia

Sep 25, 2025, 7:30 AM EDT - 5 months ago

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia

MediWound's NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress

Sep 2, 2025, 7:30 AM EDT - 6 months ago

MediWound's NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress

MediWound Is A Buy Opportunity On The Dip

Sep 2, 2025, 5:42 AM EDT - 6 months ago

MediWound Is A Buy Opportunity On The Dip

MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 20, 2025, 7:30 AM EDT - 6 months ago

MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference

MediWound Ltd. (MDWD) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 1:31 PM EDT - 6 months ago

MediWound Ltd. (MDWD) Q2 2025 Earnings Call Transcript

MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 14, 2025, 7:00 AM EDT - 6 months ago

MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update

MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers

Aug 13, 2025, 8:45 AM EDT - 7 months ago

MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers

MediWound to Report Second Quarter 2025 Financial Results

Aug 4, 2025, 7:30 AM EDT - 7 months ago

MediWound to Report Second Quarter 2025 Financial Results

MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript

May 21, 2025, 12:46 PM EDT - 9 months ago

MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 21, 2025, 7:00 AM EDT - 10 months ago

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

MediWound Ltd.: Undervalued High-Growth Potential

May 16, 2025, 10:34 AM EDT - 10 months ago

MediWound Ltd.: Undervalued High-Growth Potential

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

May 13, 2025, 7:30 AM EDT - 10 months ago

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

MediWound to Report First Quarter 2025 Financial Results

May 5, 2025, 8:00 AM EDT - 10 months ago

MediWound to Report First Quarter 2025 Financial Results

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

Apr 28, 2025, 8:00 AM EDT - 10 months ago

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 12:10 PM EDT - 1 year ago

MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 19, 2025, 7:00 AM EDT - 1 year ago

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025, 8:00 AM EST - 1 year ago

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

Feb 25, 2025, 8:00 AM EST - 1 year ago

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

MediWound to Present at the 45th Annual TD Cowen Health Care Conference

Feb 24, 2025, 8:00 AM EST - 1 year ago

MediWound to Present at the 45th Annual TD Cowen Health Care Conference

MediWound to launch Phase III trial for venous leg ulcers

Feb 12, 2025, 8:12 AM EST - 1 year ago

MediWound to launch Phase III trial for venous leg ulcers

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

Feb 12, 2025, 7:00 AM EST - 1 year ago

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript

Nov 26, 2024, 1:46 PM EST - 1 year ago

MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update

Nov 26, 2024, 7:00 AM EST - 1 year ago

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update

MediWound Is A Healthy Investment

Oct 29, 2024, 10:49 AM EDT - 1 year ago

MediWound Is A Healthy Investment

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers

Oct 10, 2024, 7:00 AM EDT - 1 year ago

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 15, 2024, 4:15 PM EDT - 1 year ago

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns

MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 3:00 PM EDT - 1 year ago

MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript

MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

Aug 14, 2024, 7:00 AM EDT - 1 year ago

MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)

Aug 5, 2024, 7:30 AM EDT - 1 year ago

MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)

MediWound to Report Second Quarter 2024 Financial Results

Aug 2, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report Second Quarter 2024 Financial Results

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers

Jul 29, 2024, 8:00 AM EDT - 1 year ago

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program

Jul 16, 2024, 7:30 AM EDT - 1 year ago

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

Jul 15, 2024, 7:32 AM EDT - 1 year ago

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

MediWound Announces $25 Million Strategic Private Placement Financing

Jul 15, 2024, 7:00 AM EDT - 1 year ago

MediWound Announces $25 Million Strategic Private Placement Financing

MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript

May 29, 2024, 11:35 AM EDT - 1 year ago

MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

May 29, 2024, 7:00 AM EDT - 1 year ago

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

MediWound to Report First Quarter 2024 Financial Results

May 22, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report First Quarter 2024 Financial Results

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

Apr 25, 2024, 8:00 AM EDT - 1 year ago

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

MediWound Ltd. (MDWD) Q4 2023 Earnings Call Transcript

Mar 21, 2024, 11:35 AM EDT - 2 years ago

MediWound Ltd. (MDWD) Q4 2023 Earnings Call Transcript

MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

Mar 21, 2024, 7:00 AM EDT - 2 years ago

MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results

Mar 14, 2024, 8:00 AM EDT - 2 years ago

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results

novelty
novelty Feb. 25 at 2:19 AM
$MDWD has to be the easiest short in the market. Dont even need to trade many shares for this thing to drop 5% rofl
0 · Reply
novelty
novelty Feb. 24 at 8:35 PM
$MDWD who buys this garbage?
0 · Reply
novelty
novelty Feb. 24 at 8:27 PM
$MDWD every share sold yesterday rofl
0 · Reply
novelty
novelty Feb. 24 at 8:26 PM
$MDWD every single penny wiped out today. Gotta love this pig. 1000000000$ short from 18
0 · Reply
novelty
novelty Feb. 24 at 7:55 PM
$MDWD puke lil piggy
0 · Reply
novelty
novelty Feb. 24 at 7:25 PM
$MDWD hahahaha
0 · Reply
novelty
novelty Feb. 24 at 7:23 PM
$MDWD don’t u guys ever learn? It always give back every single penny
0 · Reply
novelty
novelty Feb. 24 at 6:36 PM
$MDWD the stock that can’t catch a bid. Rofl
0 · Reply
novelty
novelty Feb. 24 at 6:34 PM
$MDWD nothing but big sellers yesterday exiting their longs cause they know they’re getting em back at 14$ or less
0 · Reply
novelty
novelty Feb. 24 at 6:27 PM
$MDWD Ha A Ha
0 · Reply
novelty
novelty Feb. 24 at 6:11 PM
$MDWD the invibcible level to short on holds again. Max short 18 always. Will never go higher.
0 · Reply
novelty
novelty Feb. 24 at 4:08 PM
$MDWD good to see bulls have zero interest in paying 18$
0 · Reply
novelty
novelty Feb. 24 at 3:16 PM
$MDWD bulls r such pussies. Has been all year with this name.
0 · Reply
wblb
wblb Feb. 24 at 3:09 PM
$MDWD Pay no attention to novelty the villager. He's a paid basher who will leave once the stock is 35 after interim results. Until then he will just spw his garbage and bad prognostications. Just put him on block like the restof the world has.
0 · Reply
novelty
novelty Feb. 24 at 3:06 PM
$MDWD no follow through above prior day high. As expected.
0 · Reply
novelty
novelty Feb. 24 at 1:37 PM
$MDWD insta puke off open here we go
0 · Reply
novelty
novelty Feb. 24 at 5:04 AM
$MDWD don’t get too excited. A lot of volume for a close barely above 18. We’ll retrace the move tmrw like always
0 · Reply
Its_Only_Money_369
Its_Only_Money_369 Feb. 24 at 4:23 AM
$MDWD @novelty On behalf of all the bulls, we would like to thank you for your sacrifice.
0 · Reply
novelty
novelty Feb. 23 at 8:36 PM
$MDWD unlimited shares for sale at 18
0 · Reply
novelty
novelty Feb. 23 at 3:02 PM
$MDWD rule #1 max short anything close to 18. We sweep 14 level before any uppies here
0 · Reply
novelty
novelty Feb. 23 at 2:36 PM
$MDWD as expected, bulls have zero interest with follow through on fridays candle.
0 · Reply
Its_Only_Money_369
Its_Only_Money_369 Feb. 23 at 4:25 AM
$VNDA $MDWD Has a much better setup and is primed for a good squeeze. Chart is nearly identical to Vandas before it started to run. 9 million float, 6.7 million institutional shares and 1.2 million short. Positioned to be the new SOC in debridement.
1 · Reply